🎯 FLOWCHART SUMMARY – ADRENERGIC DRUGS
ADRENERGIC SYSTEM │ ┌───────────────┴────────────────┐ │ │ Receptors Adrenergic Drugs │ │ ┌──────────┼───────────┐ ┌──────┴──────────────────────┐ │ │ │ │ │ α1 α2 β-Receptors Direct-Acting Indirect-Acting │ │ (β1, β2, β3) │ │ │ │ │ │Vasoconstr •↓NE Catecholamines NE releasersMydriasis •↓Insulin (Epi, NE, DA, Dobutamine) (Amphetamine)Urine Ret •↓SNS outflow Non-catecholamines Reuptake blockers (Salbutamol, PE, (Cocaine, TCAs) Clonidine) MAO inhibitors │ │ └──────────────────────┬─────────┘ │ Mixed Acting (Ephedrine) │ ▼ Physiological Effects │ ┌──────────────────────┬───────────────────────────┬─────────────────────┐ │ │ │ │ Cardiovascular Respiratory Eye Urogenital ↑HR (β1) Bronchodilation (β2) Mydriasis (α1) Tocolysis (β2) ↑BP (α1) ↓Allergy med ↓IOP (α2) Bladder relaxation (β3) Shock mgmt Asthma, COPD Glaucoma mgmt OAB (Mirabegron)
![]()
🎨 COLOR-CODED EXAM REVISION TABLE
(Colors shown in text form so you can
recreate easily in notes)
🔵 Blue = Classification
🟢 Green = Receptor / MOA
🟡 Yellow = Uses
🔴 Red = ADRs & Cautions
![]()
✅ 1. DRUG CLASSIFICATION TABLE
|
🔵 Class |
Drugs |
🟢 MOA |
🟡 Uses |
🔴 ADRs |
|
Direct-acting Catecholamines |
Epinephrine,
NE, Dopamine, Dobutamine, Isoproterenol |
α, β
stimulation |
Shock,
cardiac arrest, HF |
↑BP,
arrhythmia |
|
Direct-acting Non-catecholamines |
Phenylephrine,
Salbutamol, Formoterol, Clonidine, Mirabegron |
Selective
α1, α2, β2, β3 |
Asthma,
nasal congestion, OAB, hypertension |
Tremors,
rebound HTN (clonidine) |
|
Indirect-acting |
Amphetamine,
Tyramine, Cocaine, TCAs |
↑ NE
release / block reuptake |
ADHD,
depression |
Dependence,
HTN |
|
Mixed-acting |
Ephedrine,
Pseudoephedrine |
Direct +
indirect |
Nasal
decongestion |
HTN,
insomnia |
![]()
✅ 2. RECEPTOR SUMMARY TABLE
|
Receptor |
🟢 Location |
🟡 Function |
Common Drugs |
|
α1 |
Blood
vessels, eye |
↑ BP,
mydriasis |
Phenylephrine |
|
α2 |
Presynaptic
CNS |
↓ NE
release |
Clonidine,
Brimonidine |
|
β1 |
Heart,
kidney |
↑HR,
↑renin |
Dobutamine |
|
β2 |
Lungs,
uterus |
Bronchodilation,
tocolysis |
Salbutamol,
Terbutaline |
|
β3 |
Adipose,
bladder |
Lipolysis,
bladder relaxation |
Mirabegron |
|
D1/D2 |
Renal
& CNS |
Renal
vasodilation, ↓ prolactin |
Dopamine,
Bromocriptine |
![]()
✅ 3. STRUCTURE–ACTIVITY (SAR) SUMMARY TABLE
|
Structural Feature (🔵) |
Effect (🟢) |
Example |
|
Catechol OH (3,4) |
↑ Potency,
not orally active |
Epinephrine |
|
Bulky N-substituent |
↑
β-selectivity |
Isoproterenol |
|
α-Carbon substitution |
Prevents
MAO metabolism ↑ duration |
Ephedrine |
|
Lack of catechol OH |
↑ oral
absorption |
Salbutamol |
|
Imidazoline ring |
α2
selectivity |
Clonidine |
![]()
✅ 4. USES & DRUGS TABLE
|
Disorder (🟡 Yellow) |
Preferred Drug |
|
Asthma |
Salbutamol,
Formoterol |
|
COPD |
Indacaterol,
Salmeterol |
|
Nasal
congestion |
Xylometazoline,
Oxymetazoline |
|
Shock |
NE,
Dopamine |
|
Heart
failure |
Dobutamine |
|
Overactive
bladder |
Mirabegron |
|
Glaucoma |
Brimonidine |
|
ADHD |
Methylphenidate |
![]()
✅ 5. ADRs TABLE
|
🔴 ADR |
Drugs causing it |
|
Tachycardia |
β1
agonists |
|
Tremors |
β2
agonists |
|
Hypertension |
α1
agonists, NE |
|
Rebound
hypertension |
Clonidine
withdrawal |
|
CNS
stimulation |
Amphetamine |
|
Hyperglycemia |
β2
agonists |
![]()
No comments:
Post a Comment